BCKDK inhibitor (Ramino)

N/A

Report date: 2025/01/26 18:26:19
NME

Base Information

Drug NameBCKDK inhibitor (Ramino)
Drug Alias NameBCKDK inhibitor (Ramino)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBranched-chain alpha-ketoacid dehydrogenase kinase inhibitors
TargetsBranched-chain alpha-ketoacid dehydrogenase kinase
Therapy Area/IndicationsInsulin ResistanceDiabetes Mellitus, Type 2Metabolic Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRamino Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRamino Bio Ltd
Inactive CompaniesN/A
Active IndicationsInsulin ResistanceDiabetes Mellitus, Type 2Metabolic Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A